Determination of Molecular Status, as Well as the Efficacy and Safety of Fluorodeoxyglucose (18F-FDG) in PET-CT Imaging in Juvenile Patients With Histiocytosis
Condition: Histiocytosis Intervention: Drug: fluorodeoxyglucose (18F-FDG) Sponsors: Anna Raciborska; Maria Sklodowska-Curie Institute - Oncology Center; Łukasiewicz Research Network; Wrocław University of Environmental and Life Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials